Publication: Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells
dc.contributor.author | Duman, Fatma Demir | |
dc.contributor.author | Khodadust, Rouhullah | |
dc.contributor.author | Ulukaya, Engin | |
dc.contributor.author | Acar, Havva Yağcı | |
dc.contributor.buuauthor | Erkısa, Merve | |
dc.contributor.buuauthor | Arı, Ferda | |
dc.contributor.department | Fen Edebiyet Fakültesi | |
dc.contributor.department | Biyoloji Bölümü | |
dc.contributor.orcid | 0000-0002-3127-742X | |
dc.contributor.orcid | 0000-0002-6729-7908 | |
dc.contributor.researcherid | AAM-1001-2020 | |
dc.contributor.researcherid | AAG-7012-2021 | |
dc.contributor.scopusid | 57126208900 | |
dc.contributor.scopusid | 24376085300 | |
dc.date.accessioned | 2022-12-22T08:49:01Z | |
dc.date.available | 2022-12-22T08:49:01Z | |
dc.date.issued | 2017-10 | |
dc.description.abstract | We aim to develop folic acid ( FA)-conjugated cationic Ag2S near-infrared quantum dots (NIRQDs) for the delivery of doxorubicin (DOX) selectively to folate receptor (FR)-positive cancer cells to achieve enhanced drug efficacy and optical tracking in the NIR region. Materials & methods: Cationic Ag2S NIRQDs were decorated with FA using a PEG bridge and loaded with DOX. In vitro studies were performed on FR-positive human cervical carcinoma cells and FR-negative A549 cells. Results: Significantly higher uptake of DOX by human cervical carcinoma cells cells and a greater therapeutic effect along with a strong intracellular optical signal were obtained with DOX-loaded FA-conjugated Ag2S NIRQDs. Conclusion: These Ag2S NIRQDs are promising theranostic nanoparticles for receptor-mediated delivery of DOX with enhanced drug efficacy combined with optical imaging. | |
dc.identifier.citation | Duman, F. D. vd. (2017). ''Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells''. Nanomedicine, 12(19), 2319-2333. | |
dc.identifier.endpage | 2333 | |
dc.identifier.issn | 1743-5889 | |
dc.identifier.issue | 19 | |
dc.identifier.pubmed | 28875744 | |
dc.identifier.scopus | 2-s2.0-85030166267 | |
dc.identifier.startpage | 2319 | |
dc.identifier.uri | https://doi.org/10.2217/nnm-2017-0180 | |
dc.identifier.uri | https://www.futuremedicine.com/doi/10.2217/nnm-2017-0180 | |
dc.identifier.uri | 1748-6963 | |
dc.identifier.uri | http://hdl.handle.net/11452/30045 | |
dc.identifier.volume | 12 | |
dc.identifier.wos | 000411843400004 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Future Medicine | |
dc.relation.bap | BUAP(F)-2014/3 | |
dc.relation.collaboration | Yurt içi | |
dc.relation.journal | Nanomedicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.relation.tubitak | 113Z164 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Biotechnology & applied microbiology | |
dc.subject | Science & technology - other topics | |
dc.subject | Ag2S quantum dots | |
dc.subject | Cancer therapy | |
dc.subject | Doxorubicin | |
dc.subject | Near-infrared imaging; | |
dc.subject | Targeting | |
dc.subject | Drug-deliveryhig | |
dc.subject | Hly luminescent | |
dc.subject | Cytotoxicity | |
dc.subject | Folate | |
dc.subject | Cardiotoxicity | |
dc.subject | Nanoparticles | |
dc.subject | Apoptosis | |
dc.subject | Assay | |
dc.subject | Tool | |
dc.subject.emtree | Doxorubicin | |
dc.subject.emtree | Folic acid | |
dc.subject.emtree | Quantum dot | |
dc.subject.emtree | Silver sulfide quantum dot | |
dc.subject.emtree | Sulfide | |
dc.subject.emtree | Unclassified drug | |
dc.subject.emtree | Antineoplastic agent | |
dc.subject.emtree | Doxorubicin | |
dc.subject.emtree | Drug carrier | |
dc.subject.emtree | Fluorescent dye | |
dc.subject.emtree | Folic acid | |
dc.subject.emtree | Macrogol | |
dc.subject.emtree | Nanoconjugate | |
dc.subject.emtree | Quantum dot | |
dc.subject.emtree | Silver derivative | |
dc.subject.emtree | Silver sulfide | |
dc.subject.emtree | Article | |
dc.subject.emtree | Cervical cancer cell line | |
dc.subject.emtree | Controlled study | |
dc.subject.emtree | Cytotoxicity | |
dc.subject.emtree | Drug delivery system | |
dc.subject.emtree | Drug efficacy | |
dc.subject.emtree | Drug mechanism | |
dc.subject.emtree | Drug synthesis | |
dc.subject.emtree | Drug uptake | |
dc.subject.emtree | Fluorescence imaging | |
dc.subject.emtree | HeLa cell line | |
dc.subject.emtree | Human | |
dc.subject.emtree | Human cell | |
dc.subject.emtree | In vitro study | |
dc.subject.emtree | Intracellular signaling | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | Quantum yield | |
dc.subject.emtree | A-549 cell line | |
dc.subject.emtree | Apoptosis | |
dc.subject.emtree | Cell culture technique | |
dc.subject.emtree | Cell survival | |
dc.subject.emtree | Chemistry | |
dc.subject.emtree | Drug release | |
dc.subject.emtree | Fluorescence imaging | |
dc.subject.emtree | Particle size | |
dc.subject.emtree | Procedures | |
dc.subject.emtree | Surface property | |
dc.subject.emtree | HeLa cell line | |
dc.subject.mesh | A549 cells | |
dc.subject.mesh | Antineoplastic agents | |
dc.subject.mesh | Apoptosis | |
dc.subject.mesh | Cell culture techniques | |
dc.subject.mesh | Cell survival | |
dc.subject.mesh | Doxorubicin | |
dc.subject.mesh | Drug carriers | |
dc.subject.mesh | Drug liberation | |
dc.subject.mesh | Fluorescent dyes | |
dc.subject.mesh | Folic acid | |
dc.subject.mesh | HeLa cells | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Nanoconjugates | |
dc.subject.mesh | Optical imaging | |
dc.subject.mesh | Particle size | |
dc.subject.mesh | Polyethylene glycols | |
dc.subject.mesh | Quantum dots | |
dc.subject.mesh | Silver compounds | |
dc.subject.mesh | Surface properties | |
dc.subject.scopus | Nanocrystal; Cdte; Forster Resonance Energy Transfer | |
dc.subject.wos | Nanoscience & nanotechnology | |
dc.subject.wos | Biotechnology & applied microbiology | |
dc.title | Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells | |
dc.type | Article | |
dc.wos.quartile | Q1 (Biotechnology & applied microbiology) | |
dc.wos.quartile | Q2 (Nanoscience & nanotechnology) | |
dspace.entity.type | Publication | |
local.contributor.department | Fen Edebiyet Fakültesi/Biyoloji Bölümü | |
local.indexed.at | Scopus | |
local.indexed.at | WOS |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: